enalapril + lercanidipina mylan 20 mg + 10 mg comprimido revestido por película
mylan, lda. - enalapril + lercanidipina - comprimido revestido por película - 20 mg + 10 mg - lercanidipina, cloridrato 10 mg ; enalapril, maleato 20 mg - enalapril and lercanidipine - genérico - duração do tratamento: longa duração
desloratadina genepharm 5 mg comprimido revestido por película
genepharm, s.a - desloratadina - comprimido revestido por película - 5 mg - desloratadina 5 mg - desloratadine - genérico - duração do tratamento: curta ou média duração
sutent
pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - agentes antineoplásicos - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.
sunitinib accord
accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - agentes antineoplásicos - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.
pregabalina vivanta 25 mg cápsula
vivanta generics s.r.o. - pregabalina - cápsula - 25 mg - pregabalina 25 mg - pregabalin - genérico - duração do tratamento: longa duração
pregabalina vivanta 200 mg cápsula
vivanta generics s.r.o. - pregabalina - cápsula - 200 mg - pregabalina 200 mg - pregabalin - genérico - duração do tratamento: longa duração
pregabalina vivanta 225 mg cápsula
vivanta generics s.r.o. - pregabalina - cápsula - 225 mg - pregabalina 225 mg - pregabalin - genérico - duração do tratamento: longa duração
pregabalina vivanta 300 mg cápsula
vivanta generics s.r.o. - pregabalina - cápsula - 300 mg - pregabalina 300 mg - pregabalin - genérico - duração do tratamento: longa duração
pregabalina vivanta 300 mg cápsula
vivanta generics s.r.o. - pregabalina - cápsula - 300 mg - pregabalina 300 mg - pregabalin - genérico - duração do tratamento: longa duração
pregabalina vivanta 50 mg cápsula
vivanta generics s.r.o. - pregabalina - cápsula - 50 mg - pregabalina 50 mg - pregabalin - genérico - duração do tratamento: longa duração